Harshul Pandit

Dr. Harshul Pandit

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2019 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HPHarshul Pandit
Harshul Pandit
YHYoung K. Hong
Young K. Hong
YLYan Li
Yan Li
JRJack Rostas
Jack Rostas
ZPZachary Pulliam
Zachary Pulliam
Robert CG Martin IIRobert CG Martin II
Robert CG Martin II

1 February 2019 in Cellular Immunology
Verified
Journal Article
Closed access
YHYoung K. Hong
Young K. Hong
YLYan Li
Yan Li
HPHarshul Pandit
Harshul Pandit
SLSuPing Li
SuPing Li
ZPZachary Pulliam
Zachary Pulliam
Robert CG Martin IIRobert CG Martin II
Robert CG Martin II

3 August 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HPHarshul Pandit
Harshul Pandit
YLYan Li
Yan Li
XLXuanyi Li
Xuanyi Li
WZWeizhong Zhang
Weizhong Zhang
SLSuping Li
Suping Li
Robert CG Martin IIRobert CG Martin II
Robert CG Martin II
Hepatocellular carcinoma (HCC) is among the deadliest cancers due to its heterogeneity, contributing to chemoresistance and recurrence. Cancer stem-like cells (CSCs) are suggested to play an important role in HCC tumorigenesis. This study investigates the role of Wnt/β-catenin pathway in CSC enrichment and the capabilities of these CSCs in tumor initiation in orthotopic immunocompetent mouse model. HCC-CSCs were enriched using established serum-free culture method. Wnt/β-catenin pathway activation and its components were analyzed by western blot and qRT-PCR. The role of β-catenin in enrichment of CSC spheroids was confirmed using siRNA interference. Tumorigenic capabilities were confirmed using orthotopic immunocompetent mouse model by injecting 2 × 106 Hepa1–6 CSC spheroids or control cells in upper left liver lobe. The serum-free cultured Hepa1–6 cells demonstrated self-renewal, spheroid formation, higher EpCAM expression, increased Hoechst-33342 efflux, and upregulated Wnt/β-catenin signaling. Wnt/β-catenin pathway upregulation was implicated with the downstream targets, i.e., c-MYC, Cyclin-D1, and LEF1. Also, we found that GSK-3β serine-9 phosphorylation increased in Hepa1–6 spheroids. Silencing β-catenin by siRNA reversed spheroid formation phenotype. Mice injected with Hepa1–6 CSC spheroids showed aggressive tumor initiation and growth compared with mice injected with control cells. Successfully induced Hepa1–6 spheroids were identified with CSC-like properties. Aberrant β-catenin upregulation mediated by GSK-3β was observed in the Hepa1–6 spheroids. The β-catenin mediated CSC enrichment in the induced spheroids possesses the capability of tumor initiation in immunocompetent mice. Our study suggests plausible cell dedifferentiation mediated by β-catenin contributes to CSC-initiated HCC tumor growth in vivo.

4 July 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
GCGuozhen Cui
Guozhen Cui
RMRobert C. Martin
Robert C. Martin
HJHang Jin
Hang Jin
XLXingkai Liu
Xingkai Liu
HPHarshul Pandit
Harshul Pandit
YLYan Li
Yan Li
Upregulated fibroblast growth factor 19 (FGF19) expression in human hepatocellular carcinoma (HCC) specimens is associated with tumor progression and poor prognosis. Nonalcoholic steatohepatitis (NASH) patients are at high risk for malignant transformation into HCC. A steatohepatitis-HCC model was established in male C57L/J mice treated with N-nitrosodiethylamine (DEN) and high-fat diet (HFD). A mouse HCC cell line (Hepa1–6) and a mouse hepatocyte line (FL83B) were used to elucidate the mechanism by free fatty acids (FFA) treatment. FGF15, the mouse orthologue of FGF19, and it receptor fibroblast growth factor receptor4 (FGFR4) as well as co-receptor β-klotho were studied. FGF19 signaling was also studied in human samples of HCC with steatohepatitis. HCC incidence and tumor volume were significantly increased in the DEN+HFD group compared to that in the DEN+control diet (CD) group. Increased levels of FGF15/FGFR4/β-klotho, aberrant epithelial–mesenchymal transition (EMT) and Wnt/β-catenin signaling were detected in DEN+HFD mice. Blockage of the FGF15 signal can attenuate cell migration ability and aberrant EMT and Wnt/β-catenin signaling. Up-regulated FGF15/FGFR4 signaling promoted the development of HCC by activation of EMT and Wnt/β-catenin signaling in the lipid metabolic disorder microenvironment. Further investigation of FGF19/FGFR4 signaling is important for potential early diagnosis and therapeutic targeting in HCC patients.

21 July 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
YLYan Li
Yan Li
WZWeizhong Zhang
Weizhong Zhang
ADAnne Doughtie
Anne Doughtie
GCGuozhen Cui
Guozhen Cui
XLXuanyi Li
Xuanyi Li
Robert CG Martin IIRobert CG Martin II
Robert CG Martin II
Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma

17 July 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
NBNeal Bhutiani
Neal Bhutiani
YLYan Li
Yan Li
QZQianqian Zheng
Qianqian Zheng
HPHarshul Pandit
Harshul Pandit
XSXiaoju Shi
Xiaoju Shi
Robert CG Martin IIRobert CG Martin II
Robert CG Martin II